Escientia’s leadership team brings the mindset and quality orientation from source of the largest and most successful pharmaceutical campanies in the world.
Yadagiri Pendri, PHD, CEO & MD
>35 years experience
Former pharmaceutical executive with a track record in the development, technology transfer and commercialisation of several New Chemical Entities (NCE) across the globe
Held leadership roles at Process Research & Development, Bristol-Myers Squibb, USA in the development of small molecules and antibody drug conjugates (ADCs)
Technological expertise and know-how to manufacture architecturally complex intermediates and APIs by utilising state-of-the-art synthetic organic chemistry and cutting-edge technology platforms.
At Escientia, collaborated with several innovator biotech and pharmaceutical companies for successful discovery, development and commercialisation of advanced intermediates and novel APIs
Co-inventor of 15 US patents and 40 publications. Recipient of 4 Bristol-Myers Squibb Pharmaceutical Research Institute Presidents Awards.
Marcel Velterop – Co-CEO
>30 years Experience
Over 20 Years in Pharma of which 17 in the CDMO industry
Variety of global leadership roles at DSM, Dr Reddy’s, Sai Life Sciences & Jubilant Biosys.
Extensive experience in working with India and global innovators.
Worked directly on development, commercial API’s and NCE’s with 7 of the top 12 innovators.
Led logistics & commercial teams, as well as UK Based API plant and R&D centre in Cambridge, UK.
Kiran Pendri – President
>10 years experience
Experience collaborating with global pharma and biotech innovators.
Partnering with clients on all stages of clinical and commercial projects.
Commercial and operations at Escientia since its founding.